Home/Filings/4/0001209191-22-021681
4//SEC Filing

Dawson Michael John 4

Accession 0001209191-22-021681

CIK 0001357459other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 8:31 AM ET

Size

4.7 KB

Accession

0001209191-22-021681

Insider Transaction Report

Form 4
Period: 2022-03-29
Dawson Michael John
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-03-29$1.14/sh+15,000$17,09315,000 total

Issuer

PALISADE BIO, INC.

CIK 0001357459

Entity typeother

Related Parties

1
  • filerCIK 0001849790

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 8:31 AM ET
Size
4.7 KB